Coefficient Symbol Equation Limits

Similar documents
Description of Molecules with Molecular Interaction Fields (MIF)

Identification of Active Ligands. Identification of Suitable Descriptors (molecular fingerprint)

Molecular Dynamics Graphical Visualization 3-D QSAR Pharmacophore QSAR, COMBINE, Scoring Functions, Homology Modeling,..


FORCES THAT DETERMINE LIGAND-RECEPTOR INTERACTIONS

Quantitative Structure-Activity Relationship (QSAR) computational-drug-design.html

Drug Design 2. Oliver Kohlbacher. Winter 2009/ QSAR Part 4: Selected Chapters

Overview. Descriptors. Definition. Descriptors. Overview 2D-QSAR. Number Vector Function. Physicochemical property (log P) Atom

In Silico 3D QSAR Analysis of New Furanones Derivatives as Antibacterial agent

Molecular Descriptors Theory and tips for real-world applications

Internally defined distances in 3D-quantitative structure-activity relationships

Structure-Activity Modeling - QSAR. Uwe Koch

The CARSO (Computer Aided Response Surface Optimization) Procedure in Optimization Studies

In silico pharmacology for drug discovery

Statistical concepts in QSAR.

Molecular Interactions F14NMI. Lecture 4: worked answers to practice questions

Ligand-based QSAR Studies on the Indolinones Derivatives Bull. Korean Chem. Soc. 2004, Vol. 25, No

Quantitative structure activity relationship and drug design: A Review

Quantitative Structure Relaxant Activity Relationship of Benzopyran Derivatives: A GA-PLS-MLR Approach

Plan. Day 2: Exercise on MHC molecules.

molecules ISSN by MDPI

QSAR METHODS DEVELOPMENT, VIRTUAL AND EXPERIMENTAL SCREENING FOR CANNABINOID LIGAND DISCOVERY

Quiz QSAR QSAR. The Hammett Equation. Hammett s Standard Reference Reaction. Substituent Effects on Equilibria

Structural biology and drug design: An overview

Department of Pharmaceutical Chemistry, ASBASJSM College of Pharmacy, Bela (Ropar)-14011, Punjab, India.

Self-Organizing Molecular Field Analysis on a New Series of COX-2 Selective Inhibitors: 1,5-Diarylimidazoles

Machine learning for ligand-based virtual screening and chemogenomics!

Nonlinear QSAR and 3D QSAR

ISSN: ; CODEN ECJHAO E-Journal of Chemistry 2009, 6(3),

Chemical Space: Modeling Exploration & Understanding

Implementing the Fisher s Discriminant Ratio in a k-means Clustering Algorithm for Feature Selection and Data Set Trimming

Journal of Molecular Graphics and Modelling

* Author to whom correspondence should be addressed; Tel.: ; Fax:

Molecular descriptors and chemometrics: a powerful combined tool for pharmaceutical, toxicological and environmental problems.

Quantitative Structure-Activity Analysis of Triazines Immune Recognition Based on Immunoassay Data for polyclonal and Monoclonal Antibodies

International Journal of Research and Development in Pharmacy and Life Sciences. Review Article

5.1. Hardwares, Softwares and Web server used in Molecular modeling

A Review on Computational Methods in Developing Quantitative Structure-Activity Relationship (QSAR)

CHAPTER 6 QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) ANALYSIS

Notes of Dr. Anil Mishra at 1

Exploring the black box: structural and functional interpretation of QSAR models.

Affinities Prediction of Imidazobenzodiazepines Using CART Bull. Korean Chem. Soc. 2009, Vol. 30, No

Modelling of Normal Boiling Points of Hydroxyl Compounds by Radial Basis Networks

Molecular Modeling of Small Molecules as BVDV RNA-Dependent RNA Polymerase Allosteric Inhibitors

3D QSAR analysis of quinolone based s- triazines as antimicrobial agent

3D QSAR studies of Substituted Benzamides as Nonacidic Antiinflammatory Agents by knn MFA Approach

Chapter 8: Introduction to QSAR

A SAR and QSAR Study of New Artemisinin Compounds with Antimalarial Activity

QSAR Methodology and ADAPT

T. J. Hou, Z. M. Li, Z. Li, J. Liu, and X. J. Xu*,

Fondamenti di Chimica Farmaceutica. Computer Chemistry in Drug Research: Introduction

Quinazolinone Derivatives as Growth Hormone Secretagogue Receptor Inhibitors: 3D-QSAR study

Qsar study of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2 using different chemometrics tools

Molecular docking, 3D-QSAR studies of indole hydrazone as Staphylococcus aureus pyruvate kinase inhibitor

QSAR in Green Chemistry

Hydrogen Bonding & Molecular Design Peter

Studies of New Fused Benzazepine as Selective Dopamine D3 Receptor Antagonists Using 3D-QSAR, Molecular Docking and Molecular Dynamics

2D- and 3D-QSAR studies of a series of benzopyranes and benzopyrano[3,4b][1,4]-oxazines as inhibitors of the multidrug transporter P-glycoprotein

Hologram and Receptor-Guided 3D QSAR Analysis of Anilinobipyridine JNK3 Inhibitors

Development of a Structure Generator to Explore Target Areas on Chemical Space

molecules ISSN

3D QSAR and pharmacophore modeling studies on C-2 and C-4 substituted Quinazoline series as Anti-tubercular agents.

International Journal of Pharma and Bio Sciences V1(1)2010. Abhilash M

Redefined Zagreb, Randic, Harmonic and GA Indices of Graphene

Chemogenomic: Approaches to Rational Drug Design. Jonas Skjødt Møller

Molecular Modeling Study of Some Anthelmintic 2-phenyl Benzimidazole-1- Acetamides as β-tubulin Inhibitor

Structural interpretation of QSAR models a universal approach

Can we estimate the accuracy of ADMET predictions?

ORIENTAL JOURNAL OF CHEMISTRY An International Open Free Access, Peer Reviewed Research Journal.

Keywords: anti-coagulants, factor Xa, QSAR, Thrombosis. Introduction

QSAR Modeling of ErbB1 Inhibitors Using Genetic Algorithm-Based Regression

QSAR and QSPR Based Solely on Surface Properties?

A QSPR STUDY OF NORMAL BOILING POINT OF ORGANIC COMPOUNDS (ALIPHATIC ALKANES) USING MOLECULAR DESCRIPTORS. B. Souyei * and M.

Next Generation Computational Chemistry Tools to Predict Toxicity of CWAs

Analogue and Structure Based Drug Designing of Prenylated Flavonoid Derivatives as PKB/Akt1 Inhibitors

Virtual Libraries and Virtual Screening in Drug Discovery Processes using KNIME

Comparative QSAR analysis of cyclo-oxygenase2 inhibiting drugs

Gaussian Processes: We demand rigorously defined areas of uncertainty and doubt

3D-QSAR study on heterocyclic topoisomerase II inhibitors using CoMSIAy

International Journal of PharmTech Research CODEN (USA): IJPRIF, ISSN: Vol.8, No.3, pp , 2015

3D-QSAR and Cell Wall Permeability of Antitubercular Nitroimidazoles against Mycobacterium tuberculosis

QSAR studies of cytotoxic acridine 5,7-diones: A comparative study using P-VSA descriptors and topological descriptors

Navigation in Chemical Space Towards Biological Activity. Peter Ertl Novartis Institutes for BioMedical Research Basel, Switzerland

The Development of QSAR Models To Predict and Interpret the Biological Activity of Artemisinin Analogues

σ Bonded ligands: Transition Metal Alkyls and Hydrides

30 Years of Molecular Field Theory Or how. days. E. Adam Kallel. June 29, Retrophin, Inc.

Chemical Space. Space, Diversity, and Synthesis. Jeremy Henle, 4/23/2013

PaDEL-Descriptor: An Open Source Software to Calculate Molecular Descriptors and Fingerprints

3D QSAR and Pharmacophore Modelling of Selected Benzimidazole Derivatives as Factor IXa Inhibitors

Mohmed et al., IJPSR, 2016; Vol. 7(3): E-ISSN: ; P-ISSN:

QSAR Modeling of Human Liver Microsomal Stability Alexey Zakharov

QSAR STUDY OF ANTIMALARIA OF XANTHONE DERIVATIVES USING MULTIPLE LINEAR REGRESSION METHODS

Molecular Mechanics, Dynamics & Docking

Ajeet, Jour. Harmo. Res. Pharm., 2013, 2(1), 45-53

Orbital Development Kit

Prediction of the Standard Enthalpy of Formation of Pure Compounds Using Molecular Structure

REVIEW ON: QUANTITATIVE STRUCTURE ACTIVITY RELATIONSHIP (QSAR) MODELING

Full Papers. 1 Introduction. Min Yang a, Lu Zhou a *, Zhili Zuo b *, Ricardo Mancera c, Hang Song a, Xiangyang Tang d, Xiang Ma a

1.3.Software coding the model: QSARModel Molcode Ltd., Turu 2, Tartu, 51014, Estonia

Materials Informatics: Statistical Modeling in Material Science

Transcription:

1 Coefficient Symbol Equation Limits Squared Correlation Coefficient R 2 or r 2 0 r 2 N 1 2 ( Yexp, i Ycalc, i ) 2 ( Yexp, i Y ) i= 1 2 Cross-Validated R 2 q 2 r 2 or Q 2 or q 2 N 2 ( Yexp, i Ypred, i ) 1 3 Y-scrambling r 2 ys and q 2 ys r q 2 i= 1 = 1 N 1 2 i= 1 = N i= 1 ( Y exp, i Y ) 2 r 2 ys r 2 q 2 ys q 2 4 Prediction Error SDEP SDEP N i= 1 = ( Y Y 2 exp, i pred, i ) N As low as possible Introduction to Ligand-Based Drug Design Chimica Farmaceutica 2

Molecular descriptors are numerical values that characterize properties of molecules The descriptors fall into Four classes Topological Geometrical Electronic Hybrid or 3-D Descriptors Fingerprints Introduction to Ligand-Based Drug Design Chimica Farmaceutica 3

Dragon 7.0 calculates 5,270 molecular descriptors, organized in different logical blocks as in the previous versions. Blocks are further divided into sub-blocks to make management, selection, and analysis of descriptors easier. Following, the summary of molecular descriptors blocks calculated by Dragon 7.0 is reported. The complete list of all 5,270 calculated descriptor is also available. Block no. Block name # Descriptors Block no. Block name # Descriptors 1 Constitutional 47 16 RDF descriptors 210 2 Ring descriptors 32 17 3D-MoRSE descriptors 224 3 Topological indices 75 18 WHIM descriptors 114 4 Walk and path counts 46 19 GETAWAY descriptors 273 5 Connectivity indices 37 20 Randic molecular profiles 41 6 Information indices 50 21 Functional groups count 154 7 2D matrix-based descriptors 607 22 Atom-centred fragments 115 8 2D autocorrelations 213 23 Atom-type E-state indices 172 9 Burden eigenvalues 96 24 CATS 2D 150 10 P-VSA-like descriptors 55 25 2D Atom Pairs 1596 11 ETA indices 23 26 3D Atom Pairs 36 12 Edge adjacency indices 324 27 Charge descriptors 15 13 Geometrical descriptors 38 28 Molecular properties 20 14 3D matrix-based descriptors 99 29 Drug-like indices 28 15 3D autocorrelations 80 30 CATS 3D 300 Introduction to Ligand-Based Drug Design Chimica Farmaceutica 4

Description of Molecules with Molecular Interaction Fields (MIF) Introduction to Ligand-Based Drug Design Chimica Farmaceutica 5

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 6

Reduction of Dimensionality into Few New Highly Informative Entities ----- Principal Components ----- Introduction to Ligand-Based Drug Design Chimica Farmaceutica 7

PLS + MIF CoMFA! Introduction to Ligand-Based Drug Design Chimica Farmaceutica 8

Physical properties are measured for the molecule as a whole Properties are calculated using computer software No experimental constants or measurements are involved Properties are known as Fields Steric field - defines the size and shape of the molecule Electrostatic field - defines electron rich/poor regions of molecule Hydrophobic properties are relatively unimportant Advantages over classical QSAR No reliance on experimental values (i.e. logp) Can be applied to molecules with unusual substituents Not restricted to molecules of the same structural class Improved predictive capability Introduction to Ligand-Based Drug Design Chimica Farmaceutica 9

Training Set Molecular Alignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation Introduction to Ligand-Based Drug Design Chimica Farmaceutica 10

Training Set Molecular lignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation Introduction to Ligand-Based Drug Design Chimica Farmaceutica 11

Training Set Molecular Alignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation Introduction to Ligand-Based Drug Design Chimica Farmaceutica 12

Training Set Molecular Alignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation Introduction to Ligand-Based Drug Design Chimica Farmaceutica 13

Training Set Molecular lignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation Introduction to Ligand-Based Drug Design Chimica Farmaceutica 14

Training Set Molecular Alignment Molecular Interaction Fields (MIF) Model Generation Internal and External Validation SDEP = ( y y ) exp 2 / n 1 pred q 2 ( ) 2 y ( ) exp y pred / yexp = 1 y 2 Introduction to Ligand-Based Drug Design Chimica Farmaceutica 15

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 16

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 17

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 18

The Lattice Model: A General Paradigm for Shape-Related Structure/Activity Correlation Cramer, R.D., and Milne, M., Abstracts ACS Meeting, Honolulu, 1979, COMP 44. Baroni, M.; Costantino, G.; Cruciani, G.; Riganelli, D.; Valigi, R.; Clementi, S., Generating Optimal Linear Pls Estimations (Golpe) an Advanced Chemometric Tool for Handling 3D QSAR Problems. Quant Struct Act Rel 1993, 12, (1), 9 20. Introduction to Ligand-Based Drug Design Chimica Farmaceutica 19

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 20

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 21

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 22

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 23

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 24

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 25

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 26

CoMFA 3-D QSAutoGrid/R Introduction to Ligand-Based Drug Design Chimica Farmaceutica 27

GRS GRS GRS Introduction to Ligand-Based Drug Design Chimica Farmaceutica 28

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 29

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 30

Introduction to Ligand-Based Drug Design Chimica Farmaceutica 31